TherapeuticsMD (TXMD) Divestments (2010 - 2022)

TherapeuticsMD (TXMD) posted Divestments of $223.8 million for Q4 2022, up 168355.64% on a QoQ basis from -$133000.0 in Q3 2022.

TherapeuticsMD (TXMD) Divestments (2010 - 2022) Analysis & Trends

TherapeuticsMD's Divestments history runs 2 years deep, the most recent figure standing at $223.8 million for Q4 2022.

Quarterly Divestments changed N/A year-over-year to $223.8 million in Q4 2022, while the trailing twelve-month figure through Dec 2023 was $223.6 million (changed 0.08% YoY) and the FY2022 annual result came in at $223.8 million, changed N/A from the prior year.
Divestments was $223.8 million for Q4 2022 at TherapeuticsMD, up from -$133000.0 in the prior quarter.
Across five years, Divestments topped out at $223.8 million in Q4 2022 and bottomed at -$119.8 million in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	42.00 Mn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	3.28 Mn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	63.20 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	TherapeuticsMD	280,159.99	-8.14 Mn	-	-

Download Data